Developer docs
API playgroundTry for free, no card

Search company profiles

Strolll

Full company profile

uuid00006v4

Namestring
Strolll
Legal namestring
Strolll Ltd
Websiteurl
strolll.co
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Strolll is a UK-headquartered digital health company that has built an augmented reality (AR) neurorehabilitation platform for patients with neurological conditions, principally Parkinson's disease, stroke, and Multiple Sclerosis. The platform is delivered through AR glasses that overlay personalised visual cueing and therapeutic exercises onto the real-world environment, supporting gait training, motor rehabilitation, balance exercises, and cognitive tasks across the full mobility spectrum from bedside (supine/seated) through standing and walking. Two trademarked systems anchor the offering — NAVIGAIT (gait training) and REALITY DTX (digital therapeutics) — and the software is complemented by a web-based portal for clinical data management. The platform unifies three modules — Rehab Exercises, Gait Training, and Assessments — into a single clinician-facing system designed to fit into existing therapy workflows with minimal setup.

Commercially, Strolll monetises through device rental of AR hardware paired with annual software licensing, sold via enterprise field sales to hospitals, outpatient rehabilitation clinics, NHS trusts, and more recently community leisure operators. The company targets three primary use-case segments: inpatient neurological rehabilitation, outpatient rehabilitation clinics, and home/community care, with Parkinson's, stroke, and MS as the core indications. Distribution is direct, with no public pricing disclosed. The company was founded in 2018 in Stafford, UK, and has since opened a US subsidiary (Strolll Inc.) in Cleveland, Ohio, anchored by a strategic collaboration with Cleveland Clinic that included IP transfer and an equity investment.

Strolll has raised approximately £12.5 million across seed (£2.1M in October 2023 led by Midven) and Series A (£10.4M / €12.2M in March 2025 led by IW Capital), with additional participation from the EIC Accelerator, SFC Capital, Cleveland Clinic, and Propel@YH across earlier and bridge rounds. Headcount sits in the 11–50 range. The company remains privately held with no public revenue disclosures, and its commercial footprint currently rests on a limited set of named enterprise customers (Cleveland Clinic, Wave Active Health, named NHS pilots and individual clinicians), implying an early-commercial stage with concentration risk and limited revenue predictability at present.

Short descriptiontext

Strolll is a UK digital health company that delivers an augmented reality neurorehabilitation platform via AR glasses, providing gait training, rehab exercises, and assessments for patients with Parkinson's, stroke, and Multiple Sclerosis in clinical and community settings.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersStafford, United Kingdom
HQ citystring
Stafford
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neurorehabilitation technology, augmented reality therapy, digital therapeutics platform, gait training systems, neurological rehabilitation software
Industry1 code
PRIMARYEDAFAJAF
AR-Guided Learning & On-the-Job Performance Support (Step-by-Step Overlays)
Education/Education Technology (EdTech) & Digital Learning/AR/VR/XR, Simulations & Immersive Learning
NAICS code1 code
  • Services for the Elderly and Persons with Disabilities62412
SIC code1 code
  • Services-Computer Integrated Systems Design7373
Product category
Digital Therapeutics / Neurorehabilitation Software
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Device Rental
TypeSubscription Recurring
Description

AR glasses hardware rental as part of service delivery model, making the technology accessible without requiring upfront capital purchase.

strolll.co
2Software Access
TypeSubscription Recurring
Description

Licensed access to proprietary Strolll software platform including NAVIGAIT and REALITY DTX digital therapeutics modules, provided as a limited non-exclusive license.

strolll.co
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1Device rental and software access model
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed. Company operates device rental and software access model with service-level agreements.

strolll.co
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Strolll develops and sells an augmented reality (AR) neurorehabilitation platform delivered through AR glasses that overlays visual cueing and therapeutic exercises onto the real-world environment. The platform combines gait training, rehab exercises, and assessments in one system to help clinicians deliver engaging therapy for neurological conditions including Parkinson's disease, stroke, and Multiple Sclerosis. The company offers the solution as a bundled device-rental and software-access subscription sold to healthcare providers and rehabilitation settings.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Patient testimonials report improvements in walking, balance and stamina
+1 more record
Product overview1 text field

Strolll offers a unified augmented reality neurorehabilitation platform designed to help clinicians deliver engaging, high-intensity therapy for patients with neurological conditions such as Parkinson's, stroke, and Multiple Sclerosis. The platform integrates three core modules—Rehab Exercises, Gait Training, and Assessments—alongside a web-based portal for data management. Using AR glasses that overlay visual cueing onto the real-world environment, the system enables therapy delivery from bedside to home settings across inpatient, outpatient, and home care settings.

Product and service3 records
1Strolll Platform
CategoryDigital Therapeutics Platform
Description

Augmented reality neurorehabilitation platform that overlays visual cueing and therapeutic exercises onto the real-world environment, delivered through AR glasses, to help clinicians deliver engaging, high-intensity therapy for patients with neurological conditions such as Parkinson's, stroke, and Multiple Sclerosis across inpatient, outpatient, community, and home settings.

2NAVIGAIT
CategoryAR Gait Training System
Description

Proprietary AR-based gait training and mobility solution that provides consistent visual cueing to help patients with neurological conditions improve walking and movement, removing the need for manual floor markers.

3REALITY DTX
CategoryDigital Therapeutics Software
Description

Trademarked digital therapeutics system for neurorehabilitation that enables clinicians to deliver engaging therapy sessions using AR-guided exercises for motor, balance, and cognitive tasks.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Wave Active Health
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-02-12
Description

Wave Active Health operates the Downs Leisure Centre in Seaford, East Sussex, where Strolll AR glasses were deployed in a specialist health and rehabilitation suite. This marks the first deployment of Strolll technology outside a clinical setting in the UK, representing a flagship implementation in the community health space.

bbc.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-12
Description

Cleveland Clinic collaboration marks Strolll’s US market entry. The partnership involved IP transfer from Cleveland Clinic to Strolll, with Cleveland Clinic becoming a shareholder. This strategic alliance provides clinical validation, regulatory pathway support, and distribution leverage within the US healthcare system.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Saebo is an established neurorehabilitation product company selling upper-limb devices and therapy programs to clinicians and patients globally, serving as a broader incumbent in the same neurological rehab category.

TypeDirect peer
Description

MindMaze develops digital neurotherapeutics using VR/AR for stroke, brain injury, and Parkinson's rehabilitation, overlapping directly with Strolll's neurological condition focus and AR-enabled therapy delivery to hospitals and rehab clinics.

TypeDirect peer
Description

Penumbra's REAL Immersive System is an FDA-cleared VR platform for rehabilitation of stroke and other neurological conditions, making it a directly comparable immersive neuro rehab competitor sold into US hospitals.

4XRHealth
TypeDirect peer
Description

XRHealth operates a VR-based telehealth therapy platform covering neurological, orthopedic, and cognitive conditions, directly competing for the same clinician and patient population Strolll targets.

TypeDirect peer
Description

MedRhythms builds digital therapeutics for neurologic conditions (notably stroke gait and mobility), competing in the same digital neuro-rehabilitation category as Strolll with prescribed software products.

TypeDirect peer
Description

Constant Therapy Health provides a digital neuro-rehabilitation platform for speech, language, and cognitive therapy used by clinicians and patients at home, overlapping on the digital neuro rehab go-to-market and care continuum.

TypeEmerging player
Description

Neuro Rehab VR develops VR-based gamified exercises for physical, occupational, and speech therapy, addressing neurological recovery in clinical settings with a similar but VR-first approach.

TypeEmerging player
Description

Flint Rehab produces rehabilitation devices and software (e.g., MusicGlove, FitMi) for stroke and neurological recovery, comparable in clinical use case and target clinician buyer though more device-led.

TypeEmerging player
Description

Cionic develops wearable assistive technology (Neural Sleeve) for mobility impairment from neurological conditions like MS, stroke, and Parkinson's, competing for the same patient population seeking gait and mobility improvement.

10Rehabtronics
TypeEmerging player
Description

Rehabtronics builds neurorehabilitation technologies including the ReJoyce and Prelivia systems for hand/arm rehabilitation and stroke recovery, overlapping on neurological rehab device sales to clinicians.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds11 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Strolll

Digital Therapeutics / Neurorehabilitation Softwarestrolll.co

Strolll is a UK digital health company that delivers an augmented reality neurorehabilitation platform via AR glasses, providing gait training, rehab exercises, and assessments for patients with Parkinson's, stroke, and Multiple Sclerosis in clinical and community settings.

What Strolll does

Strolll is a UK-headquartered digital health company that has built an augmented reality (AR) neurorehabilitation platform for patients with neurological conditions, principally Parkinson's disease, stroke, and Multiple Sclerosis. The platform is delivered through AR glasses that overlay personalised visual cueing and therapeutic exercises onto the real-world environment, supporting gait training, motor rehabilitation, balance exercises, and cognitive tasks across the full mobility spectrum from bedside (supine/seated) through standing and walking. Two trademarked systems anchor the offering — NAVIGAIT (gait training) and REALITY DTX (digital therapeutics) — and the software is complemented by a web-based portal for clinical data management. The platform unifies three modules — Rehab Exercises, Gait Training, and Assessments — into a single clinician-facing system designed to fit into existing therapy workflows with minimal setup.

Commercially, Strolll monetises through device rental of AR hardware paired with annual software licensing, sold via enterprise field sales to hospitals, outpatient rehabilitation clinics, NHS trusts, and more recently community leisure operators. The company targets three primary use-case segments: inpatient neurological rehabilitation, outpatient rehabilitation clinics, and home/community care, with Parkinson's, stroke, and MS as the core indications. Distribution is direct, with no public pricing disclosed. The company was founded in 2018 in Stafford, UK, and has since opened a US subsidiary (Strolll Inc.) in Cleveland, Ohio, anchored by a strategic collaboration with Cleveland Clinic that included IP transfer and an equity investment.

Strolll has raised approximately £12.5 million across seed (£2.1M in October 2023 led by Midven) and Series A (£10.4M / €12.2M in March 2025 led by IW Capital), with additional participation from the EIC Accelerator, SFC Capital, Cleveland Clinic, and Propel@YH across earlier and bridge rounds. Headcount sits in the 11–50 range. The company remains privately held with no public revenue disclosures, and its commercial footprint currently rests on a limited set of named enterprise customers (Cleveland Clinic, Wave Active Health, named NHS pilots and individual clinicians), implying an early-commercial stage with concentration risk and limited revenue predictability at present.

Strolll firmographics

Firmographics
Name
Strolll
Legal name
Strolll Ltd
Website
https://strolll.co
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
Strolll is a UK digital health company that delivers an augmented reality neurorehabilitation platform via AR glasses, providing gait training, rehab exercises, and assessments for patients with Parkinson's, stroke, and Multiple Sclerosis in clinical and community settings.
Ownership category
akta.pro rank

Strolll industry classification

Industry
Product category
Digital Therapeutics / Neurorehabilitation Software
NAICS
Services for the Elderly and Persons with Disabilities (62412)
SIC
Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYEDAFAJAF
AR-Guided Learning & On-the-Job Performance Support (Step-by-Step Overlays)
Education/Education Technology (EdTech) & Digital Learning/AR/VR/XR, Simulations & Immersive Learning

Keywords

  • Neurorehabilitation technology
  • Augmented reality therapy
  • Digital therapeutics platform
  • Gait training systems
  • Neurological rehabilitation software

Where Strolll is headquartered

Location

Headquarters

HQ city
Stafford
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Strolll business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Device Rental: AR glasses hardware rental as part of service delivery model, making the technology accessible without requiring upfront capital purchase.
  2. Software Access: Licensed access to proprietary Strolll software platform including NAVIGAIT and REALITY DTX digital therapeutics modules, provided as a limited non-exclusive license.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualDevice rental and software access model

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Strolll product offering

Product offering

Core offering

Strolll develops and sells an augmented reality (AR) neurorehabilitation platform delivered through AR glasses that overlays visual cueing and therapeutic exercises onto the real-world environment. The platform combines gait training, rehab exercises, and assessments in one system to help clinicians deliver engaging therapy for neurological conditions including Parkinson's disease, stroke, and Multiple Sclerosis. The company offers the solution as a bundled device-rental and software-access subscription sold to healthcare providers and rehabilitation settings.

Product overview

Strolll offers a unified augmented reality neurorehabilitation platform designed to help clinicians deliver engaging, high-intensity therapy for patients with neurological conditions such as Parkinson's, stroke, and Multiple Sclerosis. The platform integrates three core modules—Rehab Exercises, Gait Training, and Assessments—alongside a web-based portal for data management. Using AR glasses that overlay visual cueing onto the real-world environment, the system enables therapy delivery from bedside to home settings across inpatient, outpatient, and home care settings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Strolll Platform Augmented reality neurorehabilitation platform that overlays visual cueing and therapeutic exercises onto the real-world environment, delivered through AR glasses, to help clinicians deliver engaging, high-intensity therapy for patients with neurological conditions such as Parkinson's, stroke, and Multiple Sclerosis across inpatient, outpatient, community, and home settings.
  • NAVIGAIT Proprietary AR-based gait training and mobility solution that provides consistent visual cueing to help patients with neurological conditions improve walking and movement, removing the need for manual floor markers.
  • REALITY DTX Trademarked digital therapeutics system for neurorehabilitation that enables clinicians to deliver engaging therapy sessions using AR-guided exercises for motor, balance, and cognitive tasks.

Quantifiable outcome

  • Patient testimonials report improvements in walking, balance and stamina
  • +1 more outcomes

Companies that use Strolll

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Strolll technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Strolll partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered flagship and core.

  • Wave Active HealthflagshipStrategic or Co-development Partner · 12 February 2026Wave Active Health operates the Downs Leisure Centre in Seaford, East Sussex, where Strolll AR glasses were deployed in a specialist health and rehabilitation suite. This marks the first deployment of Strolll technology outside a clinical setting in the UK, representing a flagship implementation in the community health space.
  • Cleveland CliniccoreStrategic or Co-development Partner · 12 March 2025Cleveland Clinic collaboration marks Strolll’s US market entry. The partnership involved IP transfer from Cleveland Clinic to Strolll, with Cleveland Clinic becoming a shareholder. This strategic alliance provides clinical validation, regulatory pathway support, and distribution leverage within the US healthcare system.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Strolll competitors and assessment

Company assessment

Broad incumbents

  • Saebo: Saebo is an established neurorehabilitation product company selling upper-limb devices and therapy programs to clinicians and patients globally, serving as a broader incumbent in the same neurological rehab category.

Direct peers

  • MindMaze: MindMaze develops digital neurotherapeutics using VR/AR for stroke, brain injury, and Parkinson's rehabilitation, overlapping directly with Strolll's neurological condition focus and AR-enabled therapy delivery to hospitals and rehab clinics.
  • Penumbra (REAL System): Penumbra's REAL Immersive System is an FDA-cleared VR platform for rehabilitation of stroke and other neurological conditions, making it a directly comparable immersive neuro rehab competitor sold into US hospitals.
  • XRHealth: XRHealth operates a VR-based telehealth therapy platform covering neurological, orthopedic, and cognitive conditions, directly competing for the same clinician and patient population Strolll targets.
  • MedRhythms: MedRhythms builds digital therapeutics for neurologic conditions (notably stroke gait and mobility), competing in the same digital neuro-rehabilitation category as Strolll with prescribed software products.
  • Constant Therapy Health: Constant Therapy Health provides a digital neuro-rehabilitation platform for speech, language, and cognitive therapy used by clinicians and patients at home, overlapping on the digital neuro rehab go-to-market and care continuum.

Emerging players

  • Neuro Rehab VR: Neuro Rehab VR develops VR-based gamified exercises for physical, occupational, and speech therapy, addressing neurological recovery in clinical settings with a similar but VR-first approach.
  • Flint Rehab Devices: Flint Rehab produces rehabilitation devices and software (e.g., MusicGlove, FitMi) for stroke and neurological recovery, comparable in clinical use case and target clinician buyer though more device-led.
  • Cionic: Cionic develops wearable assistive technology (Neural Sleeve) for mobility impairment from neurological conditions like MS, stroke, and Parkinson's, competing for the same patient population seeking gait and mobility improvement.
  • Rehabtronics: Rehabtronics builds neurorehabilitation technologies including the ReJoyce and Prelivia systems for hand/arm rehabilitation and stroke recovery, overlapping on neurological rehab device sales to clinicians.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Strolll social profiles

Digital presence

Strolll financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Strolll leadership team

Management profile

Number of profiles

Profiles1 record

Strolll subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Strolll funding detail

Funding detail

Funding overview

Funding rounds11 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Strolll M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Strolll

What does Strolll do?

Strolll develops and sells an augmented reality (AR) neurorehabilitation platform delivered through AR glasses that overlays visual cueing and therapeutic exercises onto the real-world environment. The platform combines gait training, rehab exercises, and assessments in one system to help clinicians deliver engaging therapy for neurological conditions including Parkinson's disease, stroke, and Multiple Sclerosis. The company offers the solution as a bundled device-rental and software-access subscription sold to healthcare providers and rehabilitation settings.

Is Strolll a public or private company?

Strolll is a private company. It is classified as venture growth investor backed and is currently operating.

When was Strolll founded?

Strolll was founded in 2018. It employs 51 to 100 people.

Where is Strolll based?

Strolll is headquartered in Stafford, United Kingdom, in the Europe region.

How does Strolll make money?

Two revenue lines are on record. Device Rental is the primary driver. The others are software Access.

Who are Strolll's main competitors?

Saebo is listed as a broad incumbent. Direct peers are MindMaze, Penumbra (REAL System), XRHealth, MedRhythms and Constant Therapy Health. Emerging players are Neuro Rehab VR, Flint Rehab Devices, Cionic and Rehabtronics.

Does Strolll have an API?

No public API is recorded for Strolll.

What industry is Strolll in?

Strolll's product category is Digital Therapeutics / Neurorehabilitation Software. Its primary akta.pro industry code is EDAFAJAF, AR-Guided Learning & On-the-Job Performance Support (Step-by-Step Overlays). Its NAICS code is 62412 and its SIC code is 7373.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SiliconluxembourgFive Innovative Solutions At Healthcare Week Luxembourg 2026Five healthcare companies showcased innovative solutions at Healthcare Week Luxembourg 2026, including a communication app for aphasia, a perimenopause platform, workplace wellbeing tools, a baby hearing test, and AR glasses for physical therapy. The event featured dozens of exhibitors and three HWL Awards winners, with Brainphonics taking the Visitors' Choice Award.TechopiaStrolll wins £4.3m backing for neurorehabStrolll secured approximately £4.3 million in Innovate UK backing for two neurorehabilitation projects. The funding covers an AI-assisted validation of neuromotor assessments and augmented reality rehabilitation for bed-bound patients. The company aims to extend its platform into additional clinical settings.StartupmagStrolll secures £4.3m backed by Innovate UK and IW CapitalStrolll, a healthtech startup, secured £4.3m in growth funding from Innovate UK and over £1m in private investment led by IW Capital. The funds will support clinical validation and new product development for augmented reality neurorehabilitation. The company aims to shorten validation cycles and expand adoption in hospitals and homes.EU-StartupsUK MedTech Strolll secures €5 million in Innovate UK funding and additional IW Capital-led investmentStrolll, a Stafford-based neurorehabilitation software company, secured €5 million in funding led by IW Capital, with Innovate UK providing a €4.18 million loan and an €813.2k GCIP award. The funds will accelerate development of StrolllAssessment and StrolllAcute, an AR system for acute patients.BBCHealth gym creates rehab space for people with long-term conditionsA health and leisure centre at Downs Leisure Centre in Seaford, East Sussex, has opened a specialist health and rehabilitation suite designed to support older adults and individuals with long-term health conditions. The facility, operated by Wave Active Health, features advanced neuro-rehabilitation technology including Strolll augmented reality glasses — marking the first time this technology has been deployed outside a clinical setting in the UK. The centre aims to provide personalised, low-impact rehabilitation in a community setting through specialist clinical expertise combined with innovative therapeutic tools.MicrosoftStrolll leverages Microsoft Azure and HoloLens to improve neurological rehabilitation delivery for patientsStrolll partnered with Leeds Teaching Hospitals NHS Trust to pilot a digital therapeutic solution for Parkinson's rehabilitation, utilizing Microsoft Azure and HoloLens 2 hardware. The pilot demonstrated increased therapy engagement, reduced costs per patient, and secured £2.4 million in NIHR funding for large-scale clinical trials across the UK.htnHealth Tech Awards 2025: A message from the winners – HTN Health Tech NewsThe Health Tech Awards 2025 winners were announced across nine categories, including Strolll for Innovation of the Year and Liva Healthcare for Best Health Tech Solution. Strolll's AR rehabilitation platform and Liva's chronic condition management were highlighted, with other winners including UCLPartners and Shrewsbury and Telford Hospital.Consonance10 Promising Neurology MedTech Startups in 2025The article highlights ten neurology MedTech startups, including Strolll, Inbrain Neuroelectronics, and Precisis, that are developing innovative treatments for conditions such as epilepsy, Parkinson's disease, and chronic pain. These companies are utilizing advanced technologies like augmented reality, graphene electrodes, closed-loop deep brain stimulation, and non-invasive ultrasound to improve patient outcomes. The piece emphasizes the dynamic growth in neurological implants and digital health solutions aimed at enhancing accessibility and quality of life.FinSMEsStrolll Raises £10.35M in Series A FundingStrolll, a UK-based digital therapeutic software company, raised £10.35M in Series A funding led by IW Capital. The funds will accelerate sales and marketing, extend product leadership, and expand its regulatory label. The company's AR-glass platform gamifies physiotherapy exercises for neurological disorders like Parkinson's and stroke.